Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

BACKGROUND: Transarterial chemoembolisation is the standard of care for intermediate stage (BCLC B) hepatocellular carcinoma, but it is challenging to decide when to repeat or stop treatment. Here we performed the first external validation of the SNACOR (tumour Size and Number, baseline Alpha-fetopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mähringer-Kunz, Aline, Weinmann, Arndt, Schmidtmann, Irene, Koch, Sandra, Schotten, Sebastian, Pinto dos Santos, Daniel, Pitton, Michael Bernhard, Dueber, Christoph, Galle, Peter Robert, Kloeckner, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923193/
https://www.ncbi.nlm.nih.gov/pubmed/29703174
http://dx.doi.org/10.1186/s12885-018-4407-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923193/
https://www.ncbi.nlm.nih.gov/pubmed/29703174
http://dx.doi.org/10.1186/s12885-018-4407-5

Ejemplares similares